Abstracts tagged "Juvenile idiopathic arthritis (JIA) and macrophage activation syndrome"

Abstract Number: 1457 • 2015 ACR/ARHP Annual Meeting
An Organ Based Diagnostic Approach to Macrophage Activating Syndrome in Children Demonstrates Impaired Reticuloendothelial System Clearance
King Soon Goh¹, Francesca Minoia², Angelo Ravelli², Randy Q. Cron³ and Bita Shakoory⁴, ¹Rheumatology, Temple University Hospital, Philadelphia, PA, ²Istituto Giannina Gaslini, Genoa, Italy, ³University of Alabama at Birmingham, Birmingham, AL, ⁴Rheumatology, George Washington University, Washington, DC
Background/Purpose: Early recognition and treatment of Macrophage Activating Syndrome (MAS) can improve outcome. Various diagnostic criteria are available to optimize the diagnosis if suspected by…
Abstract Number: 1166 • 2012 ACR/ARHP Annual Meeting
Clinical and Therapeutic Features of 312 Patients with Macrophage Activation Syndrome Enrolled in a Multinational Survey
Sergio Davì¹, Francesca Minoia¹, Erkan Demirkaya², Chiara Suffia³, Mario Abinun⁴, Amita Aggarwal⁵, Nuray Aktay Ayaz⁶, Maria Alessio⁷, Jordi Anton⁸, Maria Apaz⁶, Tadej Avcin⁹, Patrizia Barone¹⁰, Blanca E. Bica¹¹, Isabel Bolt¹², Luciana Breda¹³, Vyacheslav Chasnyk¹⁴, Rolando Cimaz⁶, Fabrizia Corona⁶, Ruben Cuttica¹⁵, Gianfranco D'Angelo¹⁶, AnnaCarin Horne¹⁷, Nicola Ruperto¹⁸, Alberto Martini¹⁹, Randy Q. Cron²⁰ and Angelo Ravelli⁶, ¹Pediatria II, Istituto Giannina Gaslini, Genova, Italy, ²International Investigator Consortium for MAS Diagnostic Criteria, Ankara, Turkey, ³Istituto di Ricovero e Cura a Carattere Scientifico G. Gaslini, Genova, Italy, ⁴International Investigator Consortium for MAS Diagnostic Criteria, Newcastle upon Tyne, United Kingdom, ⁵Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, ⁶Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy, ⁷Department of Pediatrics, Rheumatology Unit, University of Naples Federico II, Naples, Italy, ⁸Rheumatology, Hospital Sant Joan de Deu, Barcelona, Spain, ⁹International Investigator Consortium for MAS Diagnostic Criteria, Ljubljana, Slovenia, ¹⁰Azienda Policlinico Università di Catania, Catania, Italy, ¹¹International Investigator Consortium for MAS Diagnostic Criteria, Rio de Janeiro, Brazil, ¹²Kinderspital Zuerich, Universitaetskinderklinik, Zurich, Switzerland, ¹³International Investigator Consortium for MAS Diagnostic Criteria, Chieti, Italy, ¹⁴Hospital Pediatry, State Pediatric Medical University, Saint-Petersburg, Russia, ¹⁵International Investigator Consortium for MAS Diagnostic Criteria, Buenos Aires, Argentina, ¹⁶International Investigator Consortium for MAS Diagnostic Criteria, Ancona, Italy, ¹⁷Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden, ¹⁸Istituto Gaslini, Genova, Italy, ¹⁹Pediatric Rheumatology Collaborative Study Group [PRSCG], Cincinnati, OH, ²⁰Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: A multinational collaborative effort aimed to develop a new set of criteria for macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (sJIA) has…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].